244 related articles for article (PubMed ID: 28555082)
1. Identification of a novel PML-RARG fusion in acute promyelocytic leukemia.
Ha JS; Do YR; Ki CS; Lee C; Kim DH; Lee W; Ryoo NH; Jeon DS
Leukemia; 2017 Sep; 31(9):1992-1995. PubMed ID: 28555082
[No Abstract] [Full Text] [Related]
2. FISH-negative, cytogenetically cryptic acute promyelocytic leukemia.
Rashidi A; Fisher SI
Blood Cancer J; 2015 Jun; 5(6):e320. PubMed ID: 26090620
[No Abstract] [Full Text] [Related]
3. Acute promyelocytic leukemia in early pregnancy with translocation t(15;17) and variant PML/RARA fusion transcripts.
Park TS; Lee ST; Kim JS; Song J; Lee KA; Kim SJ; Seok YM; Lee HJ; Han JH; Kim JK; Lee EY; Choi JR
Cancer Genet Cytogenet; 2009 Jan; 188(1):48-51. PubMed ID: 19061780
[TBL] [Abstract][Full Text] [Related]
4. Acute promyelocytic leukemia with PML-RARA fusion on i(17q) and therapy-related acute myeloid leukemia.
Lee GY; Christina S; Tien SL; Ghafar AB; Hwang W; Lim LC; Lim TH
Cancer Genet Cytogenet; 2005 Jun; 159(2):129-36. PubMed ID: 15899384
[TBL] [Abstract][Full Text] [Related]
5. The co-expression of PML/RAR alpha and AML1/ETO fusion genes is associated with ATRA resistance.
Abreu e Lima RS; Baruffi MR; de Lima AS; de Oliveira FM; de Figueiredo-Pontes LL; Tone LG; Rogatto SR; Falcao RP; Ferrari Chauffaille Mde L; Rego EM
Br J Haematol; 2005 Feb; 128(3):407-9. PubMed ID: 15667548
[No Abstract] [Full Text] [Related]
6. All-trans retinoic acid and arsenic trioxide resistance of acute promyelocytic leukemia with the variant STAT5B-RARA fusion gene.
Strehl S; König M; Boztug H; Cooper BW; Suzukawa K; Zhang SJ; Chen HY; Attarbaschi A; Dworzak MN
Leukemia; 2013 Jul; 27(7):1606-10. PubMed ID: 23271512
[No Abstract] [Full Text] [Related]
7. [Role of retinoic acid in the treatment of acute promyelocytic leukemia].
Gutiérrez de Guzmán J; Kantarjian H
Sangre (Barc); 1993 Oct; 38(5):375-8. PubMed ID: 8140499
[No Abstract] [Full Text] [Related]
8. PML/RAR alpha(+) hypergranular acute promyelocytic leukemia (M3) developing into an M3 acute myelocytic leukemia without PML/RAR alpha.
Ruiz-Argüelles GJ; Ruiz-Delgado GJ; Reyes-Núñez V
Acta Haematol; 2000; 104(2-3):124-7. PubMed ID: 11154988
[TBL] [Abstract][Full Text] [Related]
9. Variant-type PML-RAR(alpha) fusion transcript in acute promyelocytic leukemia: use of a cryptic coding sequence from intron 2 of the RAR(alpha) gene and identification of a new clinical subtype resistant to retinoic acid therapy.
Gu BW; Xiong H; Zhou Y; Chen B; Wang L; Dong S; Yu ZY; Lu LF; Zhong M; Yin HF; Zhu GF; Huang W; Ren SX; Gallagher RE; Waxman S; Chen GQ; Wang ZG; Chen Z; Fu G; Chen SJ
Proc Natl Acad Sci U S A; 2002 May; 99(11):7640-5. PubMed ID: 12032336
[TBL] [Abstract][Full Text] [Related]
10. Isochromosome for derivative 17q in acute promyelocytic leukemia: evidence for two copies of PML-RARA and favorable response to all-trans-retinoic acid therapy.
Park JP; Fairweather RB; Mohandas TK
Genes Chromosomes Cancer; 1997 Feb; 18(2):151-3. PubMed ID: 9115966
[No Abstract] [Full Text] [Related]
11. A novel
Li J; Zhang Y; Li J; Xu Y; Zhang G
Haematologica; 2023 Feb; 108(2):627-632. PubMed ID: 36300779
[No Abstract] [Full Text] [Related]
12. Genetics of APL and the molecular basis of retinoic acid treatment.
Casini T; Grignani F; Pelicci PG
Int J Cancer; 1997 Feb; 70(4):473-4. PubMed ID: 9033658
[No Abstract] [Full Text] [Related]
13. Acute promyelocytic leukemia with a STAT5b-RARα fusion transcript defined by array-CGH, FISH, and RT-PCR.
Chen H; Pan J; Yao L; Wu L; Zhu J; Wang W; Liu C; Han Q; Du G; Cen J; Xue Y; Wu D; Sun M; Chen S
Cancer Genet; 2012 Jun; 205(6):327-31. PubMed ID: 22749039
[TBL] [Abstract][Full Text] [Related]
14. [All-trans retinoic acid therapy in acute promyelocytic leukemia--current status and prospect].
Kitamura K; Takeshita A; Ono R; Naoe T
Rinsho Ketsueki; 1996 Sep; 37(9):760-5. PubMed ID: 8914458
[No Abstract] [Full Text] [Related]
15. Identification of PML/RARalpha rearrangements in suspected acute promyelocytic leukemia using fluorescence in situ hybridization of bone marrow smears: a comparison with cytogenetics and RT-PCR in MRC ATRA trial patients. MRC Adult Leukaemia Working Party.
Iqbal S; Grimwade D; Chase A; Goldstone A; Burnett A; Goldman JM; Swirsky D
Leukemia; 2000 May; 14(5):950-3. PubMed ID: 10803535
[No Abstract] [Full Text] [Related]
16. Successful treatment of acute promyelocytic leukemia with a t(X;17)(p11.4;q21) and BCOR-RARA fusion gene.
Ichikawa S; Ichikawa S; Ishikawa I; Takahashi T; Fujiwara T; Harigae H
Cancer Genet; 2015 Apr; 208(4):162-3. PubMed ID: 25790901
[No Abstract] [Full Text] [Related]
17. Do RARA/PML fusion gene deletions confer resistance to ATRA-based therapy in patients with acute promyelocytic leukemia?
Subramaniyam S; Nandula SV; Nichols G; Weiner M; Satwani P; Alobeid B; Bhagat G; Murty VV
Leukemia; 2006 Dec; 20(12):2193-5. PubMed ID: 17008891
[No Abstract] [Full Text] [Related]
18. APL, a model disease for cancer therapies?
de Thé H; Chelbi-Alix MK
Oncogene; 2001 Oct; 20(49):7136-9. PubMed ID: 11704841
[No Abstract] [Full Text] [Related]
19. Interstitial insertion of RARα gene into PML gene in a patient with acute promyelocytic leukemia (APL) lacking the classic t(15;17).
Goldschmidt N; Yehuda-Gafni O; Abeliovich D; Slyusarevsky E; Rund D
Hematology; 2010 Oct; 15(5):332-7. PubMed ID: 20863428
[TBL] [Abstract][Full Text] [Related]
20. A novel PML-ADAMTS17-RARA gene rearrangement in a patient with pregnancy-related acute promyelocytic leukemia.
Lim G; Cho EH; Cho SY; Shin SY; Park JC; Yang YJ; Oh SH; Marschalek R; Meyer C; Park TS
Leuk Res; 2011 Jul; 35(7):e106-10. PubMed ID: 21529941
[No Abstract] [Full Text] [Related]
[Next] [New Search]
